Overexpression of recombinant human beta interferon (rhINF-β) in periplasmic space of Escherichia coli

Iranian Journal of Pharmaceutical Research

Volumn 13, Issue SUPPL, 2014, Pages 151-160

  Morowvat, Mohammad Hossein ^a   Babaeipour, Valiollah ^b,d   Rajabi Memari, Hamid ^c,d   Vahidi, Hossein ^a   Maghsoudi, Nader ^e  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MALEK ASHTAR UNIVERSITY OF TECHNOLOGY   (Iran)

^c SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

^d UNIVERSITY OF TEHRAN   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Escherichia coli; Expression system; Interferon beta; Periplasmic expression; Plasmid

Indexed keywords

HYBRID PROTEIN; ISOPROPYL THIOGALACTOSIDE; MESSENGER RNA; PERIPLASMIC PROTEIN; RECOMBINANT BETA INTERFERON;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOREACTOR EQUIPMENT; CELL CULTURE; DOT HYBRIDIZATION; ESCHERICHIA COLI; EXPRESSION VECTOR; FERMENTATION TECHNIQUE; GENE OVEREXPRESSION; HUMAN; IMMUNOBLOTTING; IN VITRO STUDY; NONHUMAN; OPTICAL DENSITY; PERIPLASMIC EXPRESSION; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; RNA EXTRACTION; SHAKE FLASK CULTURE; WESTERN BLOTTING;

EID: 84894562109     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Derynck R, Content J and DeClercq E. Isolation and structure of a human fibroblast interferon gene. Nature. (1980) 285: 542-547.
2. Lawn RM, Adelman J, Franke AE, Houck CM, Gross M, Najarian R and Goeddel DV. Human fibroblast interferon gene lacks introns. Nucleic Acids Res. (1981) 9: 1045-1052.
3. Meager A. Biological assays for interferons. J. Immunol. Meth. (2002) 261: 21-36.
4. Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR and Stark GR. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. (2007) 6: 975-90.
5. Karimi A, Ahmadi F, Parivar K, Nabiuni M, Haghighi S, Imani S and Afrouzi, H. Effect of honey bee venom on Lewis rats with experimental allergic Encephalomyelitis, a model for Multiple Sclerosis. Iran. J. Pharm. Res. (2012) 11: 671-678.
6. Tak PP, Hart BA, Kraan MC, Jonker M, Smeets TJ and Breedveld FC. The effects of interferon beta treatment on arthritis. Rheumatol. (1999) 38: 362-369.
7. Bergman SJ, Ferguson MC and Santanello C. Interferons as Therapeutic Agents for Infectious Diseases. Infect. Dis. Clin. North America (2011) 25: 819-834.
8. Monsonego J, Cessot G, Ince SE, Galazka AR and Abdul-Ahad AK. Randomised double-blind trial of recombinant interferon-beta for Condyloma acuminatum. Genitourin Med. (1996) 72: 111-114.
9. Kubo H, Ashida A, Matsumoto K, Kageshita T, Yamamoto A and Saida T. Interferon-beta therapy for malignant melanoma: the dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells. Arch. Dermatol. Res. (2008) 300: 297-301.
10. Jonasch E and Haluska FG. Interferon in oncological practice: Review of interferon biology, clinical applications, and toxicities. Oncologist. (2001) 6: 34-55.
11. Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su ZZ, Lebedeva IV, Kang DC, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S and Fisher PB. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties. Oncogene. (2001) 20: 7051-7063.
12. Aggarwal S. What>s fueling the biotech engine-2010 to 2011. Nature Biotechnol. (2011) 29: 1083-1089.
13. Soelberg Sørensen P. Interferon-beta-1a: Therapeutic effects, tolerability, current and future status in multiple sclerosis. Hot Topics Neurol. Psychiatr. (2010) 3: 7-16.
14. Mark DF, Lu SD, Creasey AA, Yamamoto R and Lin LS. Site-specific mutagenesis of the human fibroblast interferon gene. Proc. Natl. Acad. Sci. U.S.A. (1984) 81: 5662-5666.
15. Runkel L, Meier W, Pepinsky RB, Karpusas M, Whitty A, Kimball K, Brickelmaier M, Muldowney C, Jones W and Goelz SE. Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta). Pharm. Res. (1998) 15: 641-649.
16. Baneyx F. Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol. (1999) 10: 411-421.
17. Babaeipour V, Shojaosadati S.A. and Maghsoudi N. Maximizing production of human interferon-γ in HCDC of recombinant E. coli. Iran. J. Pharm. Res. (2013) 12: 563-572.
18. Mergulhão FJM, Summers DK and Monteiro GA. Recombinant protein secretion in Escherichia coli. Biotechnol. Advances (2005) 23: 177-202.
19. Ghane M, Yakhchali B, Khodabandeh M, and Malekzadeh F. Design, construction and expression of a synthetic β-interferon (IFN-β) gene in E. coli. Pakistan J. Biological. Sci. (2006) 9: 2922-2926.
20. Krishna Rao DV, Tulasi Ramu C, Venkateswara Rao J, Lakshmi Narasu M and Bhujanga Rao AKS. Cloning, high expression and purification of recombinant human intereferon-β-1b in Escherichia coli. Appli. Biochem. Biotechnol. (2009) 158: 140-154.
21. Taniguchi T, Guarente L, Roberts TM, Kimelman D, Douhan J and Ptashne M. Expression of the human fibroblast interferon gene in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. (1980) 77: 5230-5233.
22. Taniguchi T, Sakai M, Fujii-Kuriyama Y, Muramatsu M, Kobayashi S and Sudo T. Construction and Identification of a Bacterial Plasmid Containing the Human Fibroblast Interferon Gene Sequence. Proc. Jpn. Acad. Ser. B. (1979) 55: 464-9.
23. Derynck R, Remaut E, Saman E, Stanssens P, Clercq ED, Content J and Fiers W. Expression of human fibroblast interferon gene in Escherichia coli. Nature. (1980) 287: 193-197.
24. Gross G, Mayr U, Stüber D, Westphal W, Zacher M, Frank R and Blöcker H. Stabilisation of human interferon β synthesis in Escherichia coli by zinc ions. Biochim. Biophys. Acta (BBA)-Gene Structure and Expression. (1985) 825: 207-213.
25. Warne SR, Thomas CM, Nugent ME and Tacon WC. Use of a modified Escherichia coli trpR gene to obtain tight regulation of high-copy-number expression vectors. Gene. (1986) 46: 103-112.
26. Lu G and Moriyama EN. Vector NTI, a balanced all-in-one sequence analysis suite. Brief. Bioinformatics (2004) 5: 378-388.
27. Birnboim HC and Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. (1979) 7: 1513-23.
28. rded. Cold Spring Harbor Laboratory Press, New York (2001).
29. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. (1976) 72: 248-54.
30. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. (1970) 227: 680-685.
31. Papanikou E, Karamanou S and Economou A. Bacterial protein secretion through the translocase nanomachine. Nat. Rev. Microbiol. (2007) 5: 839-851.
32. Nojiri H. Impact of catabolic plasmids on host cell physiology. Curr. Opin. Biotechnol. (2013) 24: 423-430.
33. Stock JB, Rauch B and Roseman S. Periplasmic space in Salmonella typhimurium and Escherichia coli. J. Biologi. Chem. (1977) 252: 7850-7861.
34. Ghane M, Yakhchali B and Khodabandeh M. Over Expression of Biologically Active Interferon Beta Using Synthetic Gene in E. coli. J. Sci. Islamic Repub. Iran. (2008) 19: 203-209.
35. Choi JH and Lee SY. Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl. Microbiol. Biotechnol. (2004) 64: 625-635.